Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 24th June 2013
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Recognition for Scottish Beaver Trial
Five-year project shortlisted for Innovation Award

A trial to reintroduce four Eurasian beaver families to a forest in Scotland has been shortlisted for an Innovation Award.

The Scottish Beaver Trial is a five-year scientific study to monitor the group of wild beavers and assess the effect their reintroduction has on the local environment.

The trial has been shortlisted from over 70 entries across eight categories to be nominated for a 2013 Nature of Scotland Award.

Simon Jones, project manager of the trial, said: "The Scottish Beaver Trial is the first licensed mammal re-introduction trial to ever take place in the UK.

"Not only are our findings hopefully paving the way for future programmes, but we are also advising on international projects."

Mr Jones added that the trial is a "pioneering" step towards further understanding species reintroduction and how it plays a role in ecosystem restoration.

The trial, launched by the Scottish Wildlife Trust, the Royal Zoological Society of Scotland (RZSS) and the Forestry Commission Scotland in 2009, is being carried out at Knapdale Forest in the Heart of Argyll.

The winners will be announced on October 30 at the 2013 Nature of Scotland Awards ceremony, held in Edinburgh.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.